Results 231 to 240 of about 245,709 (254)

Novel concepts of cell-of origin in neuroendocrine neoplasms. [PDF]

Virchows Arch
Marinoni I, Avanthay S, Alcala N.
europepmc   +1 more source

Rethinking gastroenteropancreatic neuroendocrine neoplasms: A perspective on cellular origins, molecular mechanisms, and combination therapies. [PDF]

J Transl Int Med
Shi H, Xu S, Lin R.
europepmc   +1 more source

Extracellular vesicles isolated from frozen whole blood show biomarker potential in small intestine neuroendocrine neoplasms. [PDF]

iScience
Burman J, Fan C, El Husseiny M, Riestra PV, Sandberg A, Zambirinis CP, Kotán R, Amorim L, Gimm O, Bojmar L.   +9 more
europepmc   +1 more source

Connecting systemic inflammation to prognosis in neuroendocrine neoplasms: a biomarker-based approach. [PDF]

Front Med (Lausanne)
Iliesiu A, Gheorghişan-Gǎlǎțeanu AA, Țǎpoi DA, Lambrescu IM, Costache M, Tomescu LE, Derewicz D, Nimigean VR.   +7 more
europepmc   +1 more source

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

J Clin Endocrinol Metab
Auernhammer CJ, Wang K, Maccio U, Knösel T, Hungbauer MP, Schilbach K, Maurer J, Peischer L, Reul A, Kuzmenko E, Luca E, Hamati J, Vetter D, Oberholzer J, Fritsch R, Pacak K, Grossman AB, Beuschlein F, Reincke M, Hantel C, Zitzmann K, Nölting S.   +21 more
europepmc   +1 more source

ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin

Modern Pathology, 2013
The human insulin gene enhancer-binding protein islet-1 (ISL1) is a transcription factor involved in the differentiation of the neuroendocrine pancreatic cells.
Giuseppe Zamboni, Abbas Agaimy, Günter Klöppel   +2 more
exaly   +4 more sources

Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2021
Common to neuroendocrine neoplasms of the pancreas is their expression of synaptophysin, chromogranin A, and/or INSM1. They differ, however, in their histological differentiation and molecular profile.
Moritz Jesinghaus, Atsuko Kasajima, Günter Klöppel   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms

Head and Neck Pathology, 2022
Bruce Wenig, Özgür Mete
exaly  

Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study

Digestive and Liver Disease, 2021
Annamaria Colao, Bruno Annibale, Diego Ferone   +2 more
exaly  

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Annals of Oncology, 2020
Anders Sundin, Aurel Perren, Marianne Pavel   +2 more
exaly